Quarterly Results

202607 Results Summary

Revenue

The revenue stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

Operating Profit

Operating Profit stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

PBDT

PBDT stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

Profit Before Tax

Profit Before Tax stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

Net Profit

Net Profit stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This represents a per cent year-on-year *(YoY) decline for the same year.

  • YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Company News

More

Earnings

CategoryQ4 FY25-26Q4 FY24-25Change %FY25-26FY24-25Change %
Total Revenue2,850.002,191.5730.0410,508.318,931.9017.65
Expenses2,635.772,072.4927.189,894.178,561.2115.57
Other Income70.39128.84-45.37365.83447.14-18.18
Operating Profit214.23119.0879.90979.97817.8319.83
Depreciation183.28142.4928.63695.44534.9130.01
Interest34.0533.711.01144.11125.7914.56
Profit Before Tax67.2971.73-6.19140.42157.14-10.64
Tax-5.11-0.83515.660.210.73-71.23
Net Profit72.4072.56-0.22152.54162.11-5.90
CategoryQ4 FY25-26Q3 FY25-26Change %
Total Revenue2,850.002,804.991.60
Expenses2,635.772,623.570.47
Other Income70.3979.03-10.93
Operating Profit214.23181.4218.09
Depreciation183.28186.58-1.77
Interest34.0537.19-8.44
Profit Before Tax67.2936.6883.45
Tax-5.11-2.9175.60
Net Profit72.4039.5982.87

Research Reports

ActionTarget Price (₹)BrokerDateReports
Data Not Found

Financial Reports

Data not available.

Stock Prices Compare with Peers

Company1 Day1 Week1 Month3 Months6 Month1 Year
Data Not Found

Corporate Information

Company News

Analyst suggests Nifty strategy; bets on BSE, Delhivery, Glenmark Pharma

Ajit Mishra of Religare Broking recommends buying the shares of BSE, Delhivery, and Glenmark Pharmaceuticals today; check all the key details here

Updated On: 27 Mar 2026 | 6:42 AM IST

Delhivery shares gain 3% after EV partnership with RIDEV to deploy 150 EVs

Delhivery said the initiative forms a critical component of its strategy to decarbonise its urban delivery network and strengthen its sustainable logistics capabilities

Updated On: 17 Feb 2026 | 12:37 PM IST

Stocks to buy today: Shrikant Chouhan recommends M&M, Delhivery as top bets

Shrikant Chouhan of Kotak Securities recommends Mahindra & Mahindra and Delhivery as stocks to buy today. Check CMP, targets, support-resistance levels, and key growth triggers

Updated On: 03 Feb 2026 | 7:35 AM IST

Delhivery up 5% in 2 days post Q3; analysts see strong growth outlook

In the December quarter, the company reported profit after tax (PAT) for Q3 at ₹40 crore, as compared to ₹25 crore a year ago

Updated On: 02 Feb 2026 | 9:40 AM IST

Stocks to Watch today, Feb 1: Defence, Infra, Meesho, Ola, Sun Pharma

Stocks to Watch today, February 1, 2026: From Glenmark Pharma to Ola Electric, here are few shares that will remain in focus

Updated On: 01 Feb 2026 | 7:51 AM IST
More